Portfolio Management & Product Selection

Maximizing Value Through Strategic Portfolio Optimization

Overview

A strong and balanced product portfolio is the foundation of sustainable growth in the pharmaceutical and healthcare sectors.
At North Pharma Consulting, we help clients analyze, optimize, and expand their product portfolios to ensure maximum commercial value and long-term return on investment.

Our experts combine market intelligence, therapeutic insight, and regulatory expertise to identify the most promising opportunities and build portfolios that align with both strategic and operational goals across EU, CIS, MENA, LATAM, and Asia.

Key Challenges We Address

  • Overextended or underperforming product portfolios
  • Lack of objective criteria for product selection and prioritization
  • Limited visibility of new therapeutic or market opportunities
  • Unclear return on investment across multiple markets
  • Inconsistent coordination between regulatory, marketing, and commercial teams

Our Approach

1. Portfolio Assessment & Performance Review

We begin with a detailed portfolio audit, analyzing product performance, market potential, and alignment with business objectives.
This includes reviewing sales data, market share, regulatory status, and lifecycle stage to identify opportunities for optimization or divestment.

2. Therapeutic Area & Market Analysis

North Pharma Consulting conducts therapeutic landscape assessments to identify high-value segments, emerging treatment trends, and competitive dynamics.
We use these insights to highlight growth areas and gaps that can be addressed through new product introductions or partnerships.

3. Gap Mapping & Opportunity Identification

We evaluate your portfolio against market needs and competitor offerings, pinpointing gaps in coverage or innovation.
Our experts then recommend strategic additions — whether through in-licensing, co-development, or acquisition.

4. Product Prioritization & ROI Forecasting

Using financial modeling and market intelligence, we help you rank and prioritize products based on potential revenue, regulatory feasibility, and market access likelihood.
This ensures that investment and resources are focused on the most profitable and strategically valuable assets.

5. Long-Term Portfolio Strategy

We develop a sustainable portfolio roadmap that aligns R&D, regulatory, and commercial activities, supporting continuous growth and market adaptability.

Benefits

  • Optimized portfolio structure and improved profitability
  • Clear prioritization based on objective commercial and regulatory data
  • Early identification of high-potential therapeutic areas
  • Reduced investment risk through evidence-based decision making
  • Strategic balance between innovation and stability

Why Choose North Pharma Consulting

With over a decade of experience in regulatory affairs and business development, North Pharma Consulting bridges scientific insight with commercial strategy.
Our team provides an integrated perspective on portfolio management — helping clients strengthen their market presence, optimize resources, and achieve sustainable growth.